Across TCGA pan-cancer cohorts, GSTA8P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated GSTA8P data layer.
The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher GSTA8P RNA is associated with better overall survival. In most high-consensus cancer types, elevated GSTA8P expression acts as an unfavorable survival marker, although some lineages such as CESC and LUSC show a favorable association.
CESC, LUSC, and THCA are the cancer types where GSTA8P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.